Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo
Bharat Pateliya, Vinod Burade, S. Goswami
Topics & Concepts
DoxorubicinIn vivoNaringeninMedicineMetforminPharmacologyBreast cancerCancerChemotherapyCancer researchInternal medicineChemistryBiologyInsulinFlavonoidBiotechnologyBiochemistryAntioxidantMetabolism, Diabetes, and CancerCancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer